Figure 6: ILC2 derived IL-5 and IL-13 are required to reduce atherosclerosis. | Nature Communications

Figure 6: ILC2 derived IL-5 and IL-13 are required to reduce atherosclerosis.

From: Type-2 innate lymphoid cells control the development of atherosclerosis in mice

Figure 6

Ldlr−/ recipients of mixed bone marrow transplants of ILC2WT, ILC2KO, 80% ILC2KO with 20% IL-5+ or 80% ILC2KO with 20% IL-5KO, 80% ILC2KO with 20% IL-13+ 80% ILC2KO with 20% IL-13 were maintained on HFD for 8 weeks. Atherosclerosis in the aortic arch was quantified after Oil Red O staining, multiple comparison using Kruskal–Wallis yielded a P value of 0.03 (a). Representative images and quantification of atherosclerotic lesion size in aortic sinus of ILC2KO IL-13 and ILC2KO IL-13+ recipients (b). Proportional and numerical decrease of Arg1+ cells in aortic sinus of ILC2KO IL-13 recipients (c). Reduced collagen deposition in lesions of ILC2KO IL-13 recipients (d). Graph data points represent individual mice and statistical significance was determined by Mann–Whitney U-test or two-way ANOVA where appropriate. Scale bars: 270 μm.

Back to article page